Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03232918
PHASE4

Oxytocin and Fetal Heart Rate Changes

Sponsor: Unyime Ituk

View on ClinicalTrials.gov

Summary

The reported risk of nonreassuring fetal heart trace following neuraxial analgesia is 3-23%. This variability may be due to fluid and oxytocin management prior to and during the initiation of neuraxial analgesia. The study hypothesis is that decreasing the oxytocin infusion rate by 50 % prior to initiation of combined spinal epidural analgesia will cause a reduction in the incidence of adverse fetal heart rate changes.

Official title: A Randomized Controlled Trial Evaluating the Effect of the Oxytocin Infusion Rate on Fetal Heart Rate Changes and Maternal-Fetal Outcomes During the Initiation of Combined Spinal-Epidural Labor Analgesia

Key Details

Gender

FEMALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

730

Start Date

2019-02-20

Completion Date

2025-12-31

Last Updated

2025-06-04

Healthy Volunteers

Yes

Interventions

DRUG

Half dose Oxytocin

Patients randomized to the half dose oxytocin group will have the oxytocin infusion reduced to 50 % prior to placement of combined spinal epidural for labor analgesia

Locations (2)

University of Iowa Hospitals and Clinics

Iowa City, Iowa, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States